A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects
Clinical trial NCT02834442 · COMPLETED
Trial details
- NCT number
- NCT02834442
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2017-06-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.